SAMSUNG PHARM. Co., LTD. (001360.KS)
KRW 1603.0
(0.25%)
KRW 1603.0
(0.25%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -333.83 KRW | 32.86% |
| 2022 | -496.74 KRW | 41.72% |
| 2021 | -852.31 KRW | 9.51% |
| 2020 | -941.87 KRW | -988.05% |
| 2019 | 106.06 KRW | 361.81% |
| 2018 | -40.51 KRW | 76.57% |
| 2017 | -172.88 KRW | 71.36% |
| 2016 | -603.70 KRW | -1714.0% |
| 2015 | -33.28 KRW | 97.01% |
| 2014 | -1112.91 KRW | 21.87% |
| 2013 | -1424.43 KRW | -329.05% |
| 2012 | -332.00 KRW | -67.97% |
| 2011 | -197.65 KRW | -92.98% |
| 2010 | -102.42 KRW | -168.97% |
| 2009 | 148.50 KRW | 107.14% |
| 2008 | 71.69 KRW | 126.92% |
| 2007 | -266.28 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -61.35 KRW | 62.47% |
| 2024 Q2 | -109.18 KRW | -77.96% |
| 2023 Q3 | -83.92 KRW | -73.39% |
| 2023 Q4 | -163.48 KRW | -94.8% |
| 2023 Q1 | -5.24 KRW | 97.77% |
| 2023 FY | - KRW | 32.86% |
| 2023 Q2 | -48.40 KRW | -823.66% |
| 2022 FY | - KRW | 41.72% |
| 2022 Q1 | -38.63 KRW | 80.64% |
| 2022 Q2 | -168.51 KRW | -336.22% |
| 2022 Q3 | -45.42 KRW | 73.05% |
| 2022 Q4 | -235.17 KRW | -417.77% |
| 2021 Q3 | -100.00 KRW | -6.38% |
| 2021 Q1 | -218.00 KRW | 35.7% |
| 2021 FY | - KRW | 9.51% |
| 2021 Q2 | -94.00 KRW | 56.88% |
| 2021 Q4 | -199.56 KRW | -99.56% |
| 2020 Q2 | -121.00 KRW | 42.65% |
| 2020 Q4 | -339.03 KRW | -1983.5% |
| 2020 FY | - KRW | -988.05% |
| 2020 Q1 | -211.00 KRW | 0.0% |
| 2020 Q3 | 18.00 KRW | 114.88% |
| 2019 Q2 | -3.00 KRW | -103.37% |
| 2019 Q1 | 89.00 KRW | 205.75% |
| 2019 FY | - KRW | 361.81% |
| 2019 Q3 | -108.00 KRW | -3500.0% |
| 2018 Q4 | -84.16 KRW | -626.0% |
| 2018 Q2 | 47.00 KRW | 16106.9% |
| 2018 FY | - KRW | 76.57% |
| 2018 Q1 | 0.29 KRW | 101.77% |
| 2018 Q3 | 16.00 KRW | -65.96% |
| 2017 Q3 | -64.07 KRW | -45.91% |
| 2017 Q2 | -43.91 KRW | 27.45% |
| 2017 Q1 | -60.52 KRW | 80.52% |
| 2017 FY | - KRW | 71.36% |
| 2017 Q4 | -16.38 KRW | 74.43% |
| 2016 Q4 | -310.67 KRW | -151.6% |
| 2016 FY | - KRW | -1714.0% |
| 2016 Q3 | -123.48 KRW | -22.61% |
| 2016 Q2 | -100.71 KRW | -40.48% |
| 2016 Q1 | -71.69 KRW | -12.9% |
| 2015 Q1 | 7.68 KRW | 100.55% |
| 2015 Q2 | 171.55 KRW | 2133.72% |
| 2015 Q3 | -143.38 KRW | -183.58% |
| 2015 Q4 | -63.50 KRW | 55.71% |
| 2015 FY | - KRW | 97.01% |
| 2014 Q4 | -1397.45 KRW | -1311.57% |
| 2014 Q3 | -99.00 KRW | 14.71% |
| 2014 Q2 | -116.07 KRW | -115.86% |
| 2014 Q1 | -53.77 KRW | 96.31% |
| 2014 FY | - KRW | 21.87% |
| 2013 Q2 | 6.83 KRW | -81.39% |
| 2013 Q3 | -78.52 KRW | -1249.63% |
| 2013 Q4 | -1457.82 KRW | -1756.62% |
| 2013 Q1 | 36.70 KRW | 105.88% |
| 2013 FY | - KRW | -329.05% |
| 2012 Q2 | 15.36 KRW | -45.45% |
| 2012 Q1 | 28.16 KRW | 131.97% |
| 2012 Q3 | -20.48 KRW | -233.33% |
| 2012 Q4 | -624.27 KRW | -2948.19% |
| 2012 FY | - KRW | -67.97% |
| 2011 FY | - KRW | -92.98% |
| 2011 Q3 | -158.74 KRW | -875.1% |
| 2011 Q4 | -88.07 KRW | 44.52% |
| 2011 Q1 | 31.58 KRW | 116.42% |
| 2011 Q2 | 20.48 KRW | -35.15% |
| 2010 Q3 | 20.32 KRW | -27.84% |
| 2010 FY | - KRW | -168.97% |
| 2010 Q2 | 28.16 KRW | -31.27% |
| 2010 Q1 | 40.97 KRW | -17.75% |
| 2010 Q4 | -192.31 KRW | -1046.41% |
| 2009 Q2 | -22.19 KRW | -144.83% |
| 2009 Q3 | 71.69 KRW | 423.07% |
| 2009 Q1 | 49.50 KRW | 6211.11% |
| 2009 FY | - KRW | 107.14% |
| 2009 Q4 | 49.81 KRW | -30.52% |
| 2008 Q1 | 31.58 KRW | 138.85% |
| 2008 Q2 | 34.14 KRW | 8.11% |
| 2008 FY | - KRW | 126.92% |
| 2008 Q3 | 6.83 KRW | -79.99% |
| 2008 Q4 | -0.81 KRW | -111.86% |
| 2007 Q3 | -256.72 KRW | -657.0% |
| 2007 Q2 | 46.09 KRW | 80.82% |
| 2007 Q4 | -81.29 KRW | 68.34% |
| 2007 FY | - KRW | 0.0% |
| 2007 Q1 | 25.49 KRW | 0.0% |